| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/1999 | EP0923942A1 5alpha-REDUCTASE INHIBITORY PREPARATION FOR ORAL ADMINISTRATION, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF |
| 06/23/1999 | EP0923935A1 External preparation for curing lesioned tissues |
| 06/23/1999 | EP0923934A1 Modified release matrix formulation of cefaclor and cephalexin |
| 06/23/1999 | EP0923932A1 Composition containing antitumor agent |
| 06/23/1999 | EP0923733A1 Method for analysing absorption, distribution, metabolism, excretion (adme) and pharmacokinetics properties of compound mixtures |
| 06/23/1999 | EP0923729A1 Use of a liquid crystalline phase for determining the distribution of a chemical substance between a hydrophobic and a hydrophilic environment |
| 06/23/1999 | EP0923630A1 Cationic lipids and methods of use therefor |
| 06/23/1999 | EP0923600A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/23/1999 | EP0923383A1 Novel dispersible lipid blends and uses therefor |
| 06/23/1999 | EP0923370A2 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 06/23/1999 | EP0923312A1 Oral delivery form having a high absorption efficiency and method for making same |
| 06/23/1999 | EP0923293A1 Treatment of diarrhea |
| 06/23/1999 | EP0814660B1 Topical antimicrobial agents |
| 06/23/1999 | EP0725627B1 Orally-administered dosage form for animals, preparation method therefor and uses thereof |
| 06/23/1999 | EP0689452B1 Composition for oral administration of peptides |
| 06/23/1999 | EP0565668B1 Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer |
| 06/23/1999 | CN2325030Y Medicinal plaster |
| 06/23/1999 | CN1220629A Material having substance protected by deformable standoffs and method of making |
| 06/23/1999 | CN1220605A Nucleotide analogues for topical treatment of proliferative disease of skin |
| 06/23/1999 | CN1220600A Tetrahydrolipstatin-containing compositions |
| 06/23/1999 | CN1220598A Suspension of spraingly water-soluble acidic drug |
| 06/23/1999 | CN1220288A The use of water-soluble or water-dispersible polyurethanes as coatings or binders for pharmaceutical presentations |
| 06/23/1999 | CN1220270A Improved process for stabilizing proteins |
| 06/23/1999 | CN1220157A Kidney-tonifying life-prolonging capsule and its producing method |
| 06/23/1999 | CN1220150A Tongmai shuluo vessel-freeing injection and its preparing technology |
| 06/23/1999 | CN1220149A Anticancer analgesic plaster and its preparing method |
| 06/23/1999 | CN1220148A Method for preparing sarcandra oral ointment |
| 06/23/1999 | CN1220144A Method for preparing sugar-free lithagogue soluble granules by using dry granulating process |
| 06/23/1999 | CN1220142A Huanshiwan pill and its preparation |
| 06/23/1999 | CN1043732C Medicine membrane for curing stomatocace |
| 06/23/1999 | CN1043731C Nitrendipine adhesive plaster for curing hypertension and preparing method thereof |
| 06/22/1999 | US5914367 Polymer protein composites and methods for their preparation and use |
| 06/22/1999 | US5914352 Methods for the use of stabilized fluorocarbon emulsions |
| 06/22/1999 | US5914347 By adding to a hydroxyalkyl cellulose, evaporating the solution or dispersion to dryness under an inert atmosphere to prepare a powder; imparts oxidation resistance |
| 06/22/1999 | US5914334 Stable gel formulation for topical treatment of skin conditions |
| 06/22/1999 | US5914323 Treating hypercalcemia of malignancy, metastatic bone disease and/or metabolic bone disease by administering an isotonic aqueous alendronate solution with a buffer to maintain the ph in the range 4 to 8 to prevent precipitation |
| 06/22/1999 | US5914322 Treatment of disease and conditions |
| 06/22/1999 | US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue |
| 06/22/1999 | US5914311 Method for reducing serum lipoprotein (A) concentration |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | US5914135 Consists of a preservative-free calcium carbonate liquid antacid conataining magnesium hydroxide as ph adjusting agent; microbiodcides; treats gastrointestinal disorder such as acid indigestin, heartburn, dyspepsia, sour stomach |
| 06/22/1999 | US5914134 Process for the pulsatile delivery of diltiazem HCL and product produced thereby |
| 06/22/1999 | US5914132 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 06/22/1999 | US5914131 Hydromorphone therapy |
| 06/22/1999 | US5914130 In specifies rahges as a swallowable pills, caplets, tabletsor capsules to reduce body acid |
| 06/22/1999 | US5914128 Orally administrable solid dosage form |
| 06/22/1999 | US5914127 Isolation and uses of caveolae |
| 06/22/1999 | US5914126 Methods to deliver macromolecules to hair follicles |
| 06/22/1999 | US5914124 Alginate fibre, process for the preparation thereof and use |
| 06/22/1999 | US5914122 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 06/22/1999 | US5914118 Multi-layered drug containing film preparation having powder adhesive thereon |
| 06/22/1999 | US5914113 Inactivated immunogens from avian pathogens, an adjuvant and a live chicken anemia virus |
| 06/22/1999 | US5914098 Aerosol composition for forming a hydrated membrane, and applications thereof |
| 06/22/1999 | US5913998 Drug delivery |
| 06/17/1999 | WO1999029758A1 Positively-charged poly[alpha-(omega-aminoalkyl)glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake |
| 06/17/1999 | WO1999029735A1 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
| 06/17/1999 | WO1999029410A1 Extrusion device |
| 06/17/1999 | WO1999029364A1 Device for enhancing transdermal agent flux |
| 06/17/1999 | WO1999029348A1 Pharmaceutical hydrogel formulations, drug delivery devices and methods |
| 06/17/1999 | WO1999029343A1 Method of treating bladder cancer with wild type vaccinia virus |
| 06/17/1999 | WO1999029337A1 Stabilized teriparatide solutions |
| 06/17/1999 | WO1999029335A1 Pharmaceutical composition containing cyclosporin |
| 06/17/1999 | WO1999029331A1 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
| 06/17/1999 | WO1999029326A1 Creams containing vitamin d3 derivatives |
| 06/17/1999 | WO1999029325A1 Lotions containing vitamin d3 derivatives |
| 06/17/1999 | WO1999029322A1 Magnesium quinolone antibiotics |
| 06/17/1999 | WO1999029320A1 Novel administration form comprising an acid-labile active compound |
| 06/17/1999 | WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/17/1999 | WO1999029315A1 Taurine derivatives usable in the treatment of ophthalmic disorders |
| 06/17/1999 | WO1999029314A1 Novel salts of metformin and method |
| 06/17/1999 | WO1999029307A1 SUB-100nm BIODEGRADABLE POLYMER SPHERES CAPABLE OF TRANSPORTING AND RELEASING NUCLEIC ACIDS |
| 06/17/1999 | WO1999029306A1 Devices for cloaking transplanted cells |
| 06/17/1999 | WO1999029305A1 Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 06/17/1999 | WO1999029304A1 Method for high supercoiled dna content microspheres |
| 06/17/1999 | WO1999029303A1 Biodegradable mixed polymeric micelles for gene delivery |
| 06/17/1999 | WO1999029302A1 Drug delivery system with two-step targeting |
| 06/17/1999 | WO1999029301A2 Lipid compositions and their use |
| 06/17/1999 | WO1999029300A1 Self-emulsifying fenofibrate formulations |
| 06/17/1999 | WO1999029299A1 Novel suppository form comprising an acid-labile active compound |
| 06/17/1999 | WO1999029298A2 Device for enhancing transdermal agent flux |
| 06/17/1999 | WO1999029297A1 Osmotic dosage form comprising first and second coats |
| 06/17/1999 | WO1999029296A1 Pharmaceutical aerosol compositions |
| 06/17/1999 | WO1999029295A1 Use in a pharmaceutical composition to be administered through the nose of hydrophilic particles for delivering active agents to the central nervous system |
| 06/17/1999 | WO1999029261A1 Implantable drug delivery system |
| 06/17/1999 | WO1999029259A1 Improvements in and/or relating to delivery devices and their use |
| 06/17/1999 | WO1999017742A3 Taste masked formulations |
| 06/17/1999 | WO1999016442A3 Sustained release tablet formulation to treat parkinson disease |
| 06/17/1999 | WO1999016426A3 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 06/17/1999 | WO1999016420A9 Stabilized preparations for use in nebulizers |
| 06/17/1999 | WO1999015210A3 Bioadhesive compositions and methods for topical administration of active agents |
| 06/17/1999 | WO1998055075A3 Compositions and methods for inhibiting photoaging of skin |
| 06/17/1999 | DE19755921A1 Verfahren und Vorrichtung zur Verbesserung der Wirksamkeit von Wirkstoffen, die mindestens aus Mineralstoffen bestehen A method and apparatus for improving the efficacy of active ingredients, consisting of at least minerals |
| 06/17/1999 | DE19754940A1 Preparation and administration of plant extracts |
| 06/17/1999 | DE19754873A1 Extrusionsvorrichtung Extrusion apparatus |
| 06/17/1999 | CA2312917A1 Extrusion device |
| 06/17/1999 | CA2312731A1 Creams containing vitamin d3 derivatives |
| 06/17/1999 | CA2312060A1 Lotions containing vitamin d3 derivatives |
| 06/16/1999 | EP0922740A1 Gelling agent and gel compositions |
| 06/16/1999 | EP0922464A1 Quickly disintegrable compression-molded materials and process for producing the same |
| 06/16/1999 | EP0922463A2 Process for preparation of solid dosage forms |